Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis

References

• Zhao J, Li ZG. The challenges of early diagnosis and therapeutic prediction in rheumatoid arthritis. Int J Rheum Dis. 2018;21(12):1–6.
   Web of Science ®Google Scholar
• Livshits G, Kalinkovich A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis. Ageing Res Rev. 2019;56:100980.
   PubMed Web of Science ®Google Scholar
• Li X, Li X, Zeng T, et al. The clinical value of serum sirtuin-1 in the diagnosis of rheumatoid arthritis: a pilot study. Br J Biomed Sci. 2021;78(4):191–194.
   PubMed Web of Science ®Google Scholar
• Hu T, Liu Y, Tan L, et al. Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3eta protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis. Br J Biomed Sci. 2021;78(2):67–71.
   PubMed Web of Science ®Google Scholar
• Huang J, Zeng T, Zhang X, et al. Clinical diagnostic significance of 14-3-3eta protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis. Br J Biomed Sci. 2020;77(1):19–23.
   PubMed Web of Science ®Google Scholar
• Roodenrijs NMT, van der Goes MC, Welsing PMJ, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology (Oxford). 2021;60(8):3778–3788.
   PubMed Web of Science ®Google Scholar
• Mankia K, Siddle H, Di Matteo A, et al. A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. RMD Open. 2021;7(3):e001768.
   PubMed Web of Science ®Google Scholar
• Nikiphorou E, Santos EJF, Marques A, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis. 2021;80(10):1278–1285.
   PubMed Web of Science ®Google Scholar
• van Middelkoop M, Bennell KL, Callaghan MJ, et al. International patellofemoral osteoarthritis consortium: consensus statement on the diagnosis, burden, outcome measures, prognosis, risk factors and treatment. Semin Arthritis Rheum. 2018;47(5):666–675.
   PubMed Web of Science ®Google Scholar
• Aringer M, Costenbader K, Daikh D, et al. European league against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–1412.
   PubMed Web of Science ®Google Scholar
• Ward MM, Deodhar A, Gensler LS, et al. 2019 Update of the American college of rheumatology/spondylitis association of america/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Care Res (Hoboken). 2019;71(10):1285–1299.
   PubMed Web of Science ®Google Scholar
• Combe B, Landewe R, Daien CI, et al. 2016 Update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis. 2017;76(6):948–959.
   PubMed Web of Science ®Google Scholar
• Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League against rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9–16.
   PubMed Web of Science ®Google Scholar
• Li G, Xia Z, Liu Y, et al. SIRT1 inhibits rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and inflammatory response via suppressing NF-kappaB pathway. Biosci Rep. 2018;38(3):BSR20180541.
   Google Scholar
• Chen WG, Zhang SS, Pan S, et al. alpha-Mangostin treats early-stage adjuvant-induced arthritis of rat by regulating the CAP-SIRT1 pathway in macrophages. Drug Des Devel Ther. 2022;16:509–520.
   PubMed Web of Science ®Google Scholar
• Pei B, Chen K, Zhou S, et al. IL-38 restrains inflammatory response of collagen-induced arthritis in rats via SIRT1/HIF-1alpha signaling pathway. Biosci Rep. 2020;40(5):BSR20182431.
   Google Scholar
• Hao L, Wan Y, Xiao J, et al. A study of Sirt1 regulation and the effect of resveratrol on synoviocyte invasion and associated joint destruction in rheumatoid arthritis. Mol Med Rep. 2017;16(4):5099–5106.
   PubMed Web of Science ®Google Scholar
• Sujitha S, Rasool M. MicroRNAs and bioactive compounds on TLR/MAPK signaling in rheumatoid arthritis. Clin Chim Acta. 2017;473:106–115.
   PubMed Web of Science ®Google Scholar
• Wu YJ, Fang WJ, Pan S, et al. Regulation of Sirt1 on energy metabolism and immune response in rheumatoid arthritis. Int Immunopharmacol. 2021;101(Pt A):108175.
   PubMedGoogle Scholar
• Pasquereau S, Totoson P, Nehme Z, et al. Impact of glucocorticoids on systemic sirtuin 1 expression and activity in rats with adjuvant-induced arthritis. Epigenetics. 2021;16(2):132–143.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu Y, Xiong P, et al. Effects of mimicked acetylated HMGB1 on macrophages and dendritic cells. Mol Med Rep. 2018;18(6):5527–5535.
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Kawakami Y, Maruyama I, et al. HMGB proteins and arthritis. Hum Cell. 2018;31(1):1–9.
   PubMed Web of Science ®Google Scholar